New Market Study Published: Cognitive Impairment Associated with Schizophrenia (CIAS) - Pipeline Review, H2 2013
Global Markets Direct's, 'Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Cognitive Impairment Associated With Schizophrenia (CIAS), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cognitive Impairment Associated With Schizophrenia (CIAS). Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, Half Year is built using...
View full press release